Glycosylation differences of an anti-VEGF monoclonal antibody (PRO-169) and its extensive comparison with Bevacizumab
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glycosylation differences of an anti-VEGF monoclonal antibody (PRO-169) and its extensive comparison with Bevacizumab
Authors
Keywords
-
Journal
BIOLOGICALS
Volume 84, Issue -, Pages 101711
Publisher
Elsevier BV
Online
2023-09-23
DOI
10.1016/j.biologicals.2023.101711
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structural and Functional Analysis of CEX Fractions Collected from a Novel Avastin® Biosimilar Candidate and Its Innovator: A Comparative Study
- (2022) Busra Gurel et al. Pharmaceutics
- LC–MS based case-by-case analysis of the impact of acidic and basic charge variants of bevacizumab on stability and biological activity
- (2021) Sumit Kumar Singh et al. Scientific Reports
- Oxidation and Deamidation of Monoclonal Antibody Products: Potential Impact on Stability, Biological Activity, and Efficacy
- (2021) Surbhi Gupta et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Efficacy & Safety of Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Non-small Cell Lung Cancer(MAPLE):A Randomized,Double-blind,Phase 3 Study
- (2019) Nicholas Thatcher et al. CLINICAL CANCER RESEARCH
- Comparing The Efficacy Of An Anti-Human VEGF-A Neutralizing Antibody Versus Bevacizumab On A Laser-Induced Choroidal Neovascularization (CNV) Rhesus Monkey Model
- (2019) Oscar Olvera-Montaño et al. Drug Design Development and Therapy
- Supplementing glycosylation: A review of applying nucleotide-sugar precursors to growth medium to affect therapeutic recombinant protein glycoform distributions
- (2018) Eric J.M. Blondeel et al. BIOTECHNOLOGY ADVANCES
- The Impact of Prefilled Syringes on Endophthalmitis following Intravitreal Injection of Ranibizumab
- (2018) Philip P. Storey et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Biosimilarity assessment of biosimilar therapeutic monoclonal antibodies
- (2018) Akiko Ishii-Watabe et al. Drug Metabolism and Pharmacokinetics
- Glyco-Engineering of Human IgG-Fc to Modulate Biologic Activities
- (2016) Roy Jefferis CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Antidrug Antibody Formation in Oncology: Clinical Relevance and Challenges
- (2016) Emilie M.J. van Brummelen et al. ONCOLOGIST
- Ranibizumab Prefilled Syringes: Benefits of Reduced Syringe Preparation Times and Less Complex Preparation Procedures
- (2015) Eric Souied et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- Antibody Glycosylation and Its Impact on the Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies and Fc-Fusion Proteins
- (2015) Liming Liu JOURNAL OF PHARMACEUTICAL SCIENCES
- Recommendations for the development and validation of confirmatory anti-drug antibody assays
- (2015) Darshana Jani et al. Bioanalysis
- Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants
- (2015) Tetyana Dashivets et al. PLoS One
- Influence of glycosylation pattern on the molecular properties of monoclonal antibodies
- (2014) Kai Zheng et al. mAbs
- Statistical methods and tool for cut point analysis in immunogenicity assays
- (2013) Lanju Zhang et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial
- (2013) Usha Chakravarthy et al. LANCET
- A Brief History of Anti-VEGF for the Treatment of Ocular Angiogenesis
- (2012) Leo A. Kim et al. AMERICAN JOURNAL OF PATHOLOGY
- Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
- (2012) Daniel F. Martin et al. OPHTHALMOLOGY
- Glycosylation profiles of therapeutic antibody pharmaceuticals
- (2011) Christoph Wacker et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans
- (2011) A. M. Goetze et al. GLYCOBIOLOGY
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Influence of Non-Toxic Doses of Bevacizumab and Ranibizumab on Endothelial Functions and Inhibition of Angiogenesis
- (2010) Aya Barzelay et al. CURRENT EYE RESEARCH
- Charge variants in IgG1
- (2010) Leslie A. Khawli et al. mAbs
- Investigation of the role of neutralizing antibodies against bevacizumab as mediators of tachyphylaxis
- (2009) Farzin Forooghian et al. ACTA OPHTHALMOLOGICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now